Literature DB >> 7060848

Relationship between glycosylation of haemoglobin and the duration of diabetes: a study during the third trimester of pregnancy.

H Madsen, J J Kjaergaard, J Ditzel.   

Abstract

The relationship between blood glucose and glycosylated haemoglobin (HbAlc) had been investigated during an 8 week period in 53 Type 1 (insulin-dependent) diabetic women studied during the third trimester of pregnancy. Blood glucose estimations (fasting and 2h post-prandially) were made an average of 41 times in each patient during this period and HbAlc was determined once at the end of the study. There was a significant correlation between both the mean blood glucose over the preceding 8 weeks and the standard deviation of the fasting blood glucose with HbAlc (r = 0.69, p less than 0.001; r = 0.46, p less than 0.001, respectively). A "glycosylation index" was calculated for each patient (HbAlc divided by the mean blood glucose value). There was a significant correlation between the "glycosylation index" and duration of diabetes (r = 0.68, p less than 0.001). In contrast, there was no correlation between red cell 2,3-diphosphoglycerate and HbAlc or "glycosylation index". These findings suggest that increasing duration of diabetes influences the post-translational formation of HbAlc and that isolated HbAlc values need to be interpreted with caution in the pregnant diabetic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060848     DOI: 10.1007/bf00253867

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Immunologic studies of hemoglobins. III. Fetal hemoglobin changes in the circulation of pregnant women.

Authors:  D L RUCKNAGEL; A I CHERNOFF
Journal:  Blood       Date:  1955-11       Impact factor: 22.113

2.  Hemoglobin components in patients with diabetes mellitus.

Authors:  L A Trivelli; H M Ranney; H T Lai
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

3.  [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)].

Authors:  D Banauch; W Brümmer; W Ebeling; H Metz; H Rindfrey; H Lang; K Leybold; W Rick; H J Staudinger
Journal:  Z Klin Chem Klin Biochem       Date:  1975-03

4.  Glycosylated hemoglobin in relation to rapid fluctuations in blood glucose in children with insulin-dependent diabetes: a comparison of methods with and without prior dialysis.

Authors:  J Ditzel; J J Kjaergaard; R Kawahara; G Z Ostergaard; T Mourits-Andersen
Journal:  Diabetes Care       Date:  1981 Sep-Oct       Impact factor: 19.112

5.  Hemoglobin A1c as an indicator of long term blood glucose levels in diabetics with special reference to diabetic pregnancy.

Authors:  J J Kjaergaard; P Hansen; H Madsen; J Ditzel
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1980

6.  Rapid fluctuations in glycohemoglobin (hemoglobin Alc) related to acute changes in glucose.

Authors:  J A Widness; T L Rogler-Brown; K L McCormick; K S Petzold; J B Susa; H C Schwartz; R Schwartz
Journal:  J Lab Clin Med       Date:  1980-03

7.  Effects of pregnancy on hemoglobin AIc in normal, gestational diabetic, and diabetic women.

Authors:  H C Schwartz; K C King; A L Schwartz; D Edmunds; R Schwartz
Journal:  Diabetes       Date:  1976-12       Impact factor: 9.461

8.  Glycosylation of hemoglobin in vitro: affinity labeling of hemoglobin by glucose-6-phosphate.

Authors:  D N Haney; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

9.  The glycosylation of hemoglobin: relevance to diabetes mellitus.

Authors:  H F Bunn; K H Gabbay; P M Gallop
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  1 in total

1.  The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial.

Authors:  James M Hempe; Shuqian Liu; Leann Myers; Robert J McCarter; John B Buse; Vivian Fonseca
Journal:  Diabetes Care       Date:  2015-04-17       Impact factor: 19.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.